Global Cell Analysis Market 2016-2020
About Cell Analysis
Cell analysis helps identify and map many of the basic biochemical and physical processes of life. Bio-specimen preparation, cell and tissue separation, and characterization products are used to isolate and assess cells. Cell analysis products are used by various industries including biotechnology, pharmaceutical, research, and contract research organizations (CROs). They have a wide range of applications in drug discovery and development, stem cell research, cell biology, and other research practices. These technologies help analyze the internal structure of cells, their characteristics, cellular pathways, and the cellular response to any component such as a drug.
Technavio’s analysts forecast the global cell analysis market to grow at a CAGR of 7.08% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global cell analysis market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sale of the instruments, and consumables.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Cell Analysis Market 2016-2020
Technavio recognizes the following companies as the key players in the global cell analysis market: BD, Danaher, EMD Millipore, Thermo Fisher Scientific, and GE Healthcare.
Other Prominent Vendors in the market are: Abcam, AccuBioTech, Agilent Technologies, ChemoMetec A/S, Convance, EKF Diagnostic, ERBA Mannheim, Horiba Scientific, Icon, Illumina, Logos Biosystem, Mindray, Olympus Life Science Solutions, PerkinElmer, Quintiles, SFRI, Sigma-Aldrich, Sysmex, and Worthington Biochemical.
Commenting on the report, an analyst from Technavio’s team said: “Increasing number of diagnostic centers will be a key trend for market growth. An ever-changing consumer demand has resulted in shifting diagnostic testing from hospitals and commercial laboratories closer to the patients' homes, which lessens the cost of testing. However, in many countries, most of the healthcare services delivered are primarily for urban areas with a very less focus on rural areas. Many developing countries have a high percentage of people living in the rural areas where diagnostic centers are fewer and have considerably lesser accessibility compared to urban areas.”
According to the report, automation of equipment will be a key driver for market growth. Automation of equipment improves speed and accuracy of blood analysis. Advances in automated cell counters have improved the speed and accuracy of blood analysis. Automated cell counters use optical light scattering and changes in electrical current. In modern automated hematology instruments, continuous improvements have enabled enumeration and evaluation of blood cells with great precision at low cost.
Further, the report states that the laws and regulations for the approval process for diagnostics devices vary across countries, which is a major challenge faced by vendors. In addition, any change in regulatory policies during the product development period could delay the entry of potential products into the market. Many developed countries such as the US, the UK, Germany, France, Japan, Singapore, and South Korea have strict regulations regarding the approval and marketing of diagnostics products.
BD, Danaher, EMD Millipore, Thermo Fisher Scientific, and GE Healthcare. Other Prominent Vendors in the market are: Abcam, AccuBioTech, Agilent Technologies, ChemoMetec A/S, Convance, EKF Diagnostic, ERBA Mannheim, Horiba Scientific, Icon, Illumina, Logos Biosystem, Mindray, Olympus Life Science Solutions, PerkinElmer, Quintiles, SFRI, Sigma-Aldrich, Sysmex, and Worthington Biochemical.